Genus plc
OTC: GENSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jorgen Kokke
- Employees
- 3,500
- Headquarters
- Basingstoke, United Kingdom
- IPO year
- 2009
- Market cap
- $2.1B
- Website
- https://www.genusplc.com
Loading GENSF…
Loading profile data…Frequently asked questions about GENSF
What does Genus plc (GENSF) do?
Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supp...
Where does GENSF trade?
Genus plc (GENSF) trades on the Other OTC.
What sector is GENSF in?
Genus plc (GENSF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genus plc?
Jorgen Kokke is the chief executive officer of Genus plc (GENSF).
Where is Genus plc headquartered?
Genus plc is headquartered in United Kingdom.
Does GENSF pay a dividend?
Yes — Genus plc (GENSF) paid a trailing twelve-month dividend of USD 0.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GENSF go public?
Genus plc (GENSF) completed its initial public offering in 2009.